0.00 NA (NA%)
- XNAS Volume
XNAS 21 Mar, 2025 5:30 PM (EDT)
Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|
Economides Vassiliki | EVP, CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 0.02 per share. | 18 Dec 2024 | 12,000 | 250,437 (0%) | 0% | 0.0 | 180 | Common Stock |
Andrew R. Allen | Director, PRESIDENT AND CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Jun 2024 | 325,000 | 985,360 (2%) | 0% | 0 | Common Stock | |
Andrew R. Allen | Director, PRESIDENT AND CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Jun 2024 | 325,000 | 1,124,275 (3%) | 0% | 0 | Common Stock | |
Stephen W. Webster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 7,379 | 7,379 | - | - | Stock Option (Right to Buy) | |
Naiyer A. Rizvi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 51,800 | 51,800 | - | - | Stock Option (Right to Buy) | |
Shefali Agarwal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 51,800 | 51,800 | - | - | Stock Option (Right to Buy) | |
Clare Fisher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 51,800 | 51,800 | - | - | Stock Option (Right to Buy) | |
Lawrence Corey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 51,800 | 51,800 | - | - | Stock Option (Right to Buy) | |
Andrew R. Allen | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 615,000 | 615,000 | - | - | Stock Option (Right to Buy) | |
Andrew R. Allen | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 0.75 per share. | 15 May 2024 | 24,263 | 985,360 (2%) | 0% | 0.7 | 18,156 | Common Stock |
Andrew R. Allen | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 47,873 | 1,009,623 (2%) | 0% | 0 | Common Stock | |
Erin Jones | EVP, CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 27,128 | 373,042 (1%) | 0% | 0 | Common Stock | |
Erin Jones | EVP, CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 235,000 | 235,000 | - | - | Stock Option (Right to Buy) | |
Erin Jones | EVP, CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 0.75 per share. | 15 May 2024 | 13,749 | 359,293 (1%) | 0% | 0.7 | 10,288 | Common Stock |
Matthew J. Hawryluk | EVP, CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 0.75 per share. | 15 May 2024 | 9,259 | 313,931 (0%) | 0% | 0.7 | 6,929 | Common Stock |
Matthew J. Hawryluk | EVP, CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 180,000 | 180,000 | - | - | Stock Option (Right to Buy) | |
Matthew J. Hawryluk | EVP, CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 19,149 | 323,190 (0%) | 0% | 0 | Common Stock | |
Karin Jooss | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 27,128 | 697,275 (1%) | 0% | 0 | Common Stock | |
Karin Jooss | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 235,000 | 235,000 | - | - | Stock Option (Right to Buy) | |
Karin Jooss | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 0.75 per share. | 15 May 2024 | 13,749 | 683,526 (1%) | 0% | 0.7 | 10,288 | Common Stock |
Vassiliki Economides | EVP, CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 215,000 | 215,000 | - | - | Stock Option (Right to Buy) | |
Vassiliki Economides | EVP, CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 27,128 | 276,186 (0%) | 0% | 0 | Common Stock | |
Vassiliki Economides | EVP, CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 0.75 per share. | 15 May 2024 | 13,749 | 262,437 (0%) | 0% | 0.7 | 10,288 | Common Stock |
James Cho | SVP, CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 10,800 | 155,123 (0%) | 0% | 0 | Common Stock | |
James Cho | SVP, CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 65,400 | 65,400 | - | - | Stock Option (Right to Buy) | |
Stephen W. Webster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 103,600 | 103,600 | - | - | Stock Option (Right to Buy) | |
Erin Jones | EVP, CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 235,000 | 235,000 | - | - | Stock Option (Right to Buy) | |
Matthew J. Hawryluk | EVP, CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 35,000 | 286,880 (0%) | 0% | 0 | Common Stock | |
Jooss Karin | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 40,000 | 648,851 (1%) | 0% | 0 | Common Stock | |
Allen R. Andrew | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 615,000 | 615,000 | - | - | Stock Option (Right to Buy) | |
Andrew R. Allen | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 105,000 | 899,345 (2%) | 0% | 0 | Common Stock | |
Vassiliki Economides | EVP, CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 215,000 | 215,000 | - | - | Stock Option (Right to Buy) | |
Vassiliki Economides | EVP, CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 35,000 | 227,762 (0%) | 0% | 0 | Common Stock | |
J. Matthew Hawryluk | EVP, CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 180,000 | 180,000 | - | - | Stock Option (Right to Buy) | |
Cho James | SVP, CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 109,000 | 109,000 | - | - | Stock Option (Right to Buy) | |
Jones Erin | EVP, CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 40,000 | 324,618 (0%) | 0% | 0 | Common Stock | |
James Cho | SVP, CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 18,000 | 138,644 (0%) | 0% | 0 | Common Stock | |
Jooss Karin | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 235,000 | 235,000 | - | - | Stock Option (Right to Buy) | |
Steve E. Krognes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 51,800 | 51,800 | - | - | Stock Option (Right to Buy) | |
Naiyer Rizvi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 51,800 | 51,800 | - | - | Stock Option (Right to Buy) | |
Shefali Agarwal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 51,800 | 51,800 | - | - | Stock Option (Right to Buy) | |
Clare Fisher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 51,800 | 51,800 | - | - | Stock Option (Right to Buy) | |
Lawrence Corey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 51,800 | 51,800 | - | - | Stock Option (Right to Buy) | |
Vassiliki Economides | See Remarks | Purchase of securities on an exchange or from another person at price $ 1.90 per share. | 23 May 2023 | 12,000 | 214,058 (0%) | 0% | 1.9 | 22,829 | Common Stock |
Andrew R. Allen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 738,550 | 856,750 (2%) | 2% | 0 | Common Stock | |
Erin Jones | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 252,845 | 305,914 (0%) | 0% | 0 | Common Stock | |
Matthew Hawryluk | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 191,771 | 248,311 (0%) | 0% | 0 | Common Stock | |
Karin Jooss | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 252,763 | 630,147 (1%) | 0% | 0 | Common Stock | |
Vassiliki Economides | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 179,058 | 202,058 (0%) | 0% | 0 | Common Stock | |
James Cho | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 64,515 | 111,407 (0%) | 0% | 0 | Common Stock | |
Lawrence Corey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2022 | 38,000 | 38,000 | - | - | Stock Option (Right to Buy) | |
Richard A. Heyman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
Steve E. Krognes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
Naiyer Rizvi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
Shefali Agarwal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
Clare Fisher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 8,693 | 8,693 | - | - | Stock Option (Right to Buy) | |
Andrew R. Allen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 410,000 | 410,000 | - | - | Stock Option (Right to Buy) | |
Andrew R. Allen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 70,000 | 118,200 (0%) | 0% | 0 | Common Stock | |
Erin Jones | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 163,013 | 163,013 | - | - | Stock Option (Right to Buy) | |
Erin Jones | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 27,169 | 53,069 (0%) | 0% | 0 | Common Stock | |
Matthew Hawryluk | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 21,612 | 53,351 (0%) | 0% | 0 | Common Stock | |
Matthew Hawryluk | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 129,675 | 129,675 | - | - | Stock Option (Right to Buy) | |
Karin Jooss | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 27,600 | 377,384 (1%) | 0% | 0 | Common Stock | |
Karin Jooss | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 165,600 | 165,600 | - | - | Stock Option (Right to Buy) | |
Vassiliki Economides | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 138,000 | 138,000 | - | - | Stock Option (Right to Buy) | |
Vassiliki Economides | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 23,000 | 23,000 (0%) | 0% | 0 | Common Stock | |
Rahsaan Thompson | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 115,440 | 115,440 | - | - | Stock Option (Right to Buy) | |
Rahsaan Thompson | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 19,240 | 58,698 (0%) | 0% | 0 | Common Stock | |
James Cho | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 4,400 | 43,505 (0%) | 0% | 0 | Common Stock | |
James Cho | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 26,300 | 26,300 | - | - | Stock Option (Right to Buy) | |
Clare Fisher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 38,000 | 38,000 | - | - | Stock Option (Right to Buy) | |
Erin Jones | See Remarks | Sale of securities on an exchange or to another person at price $ 11.14 per share. | 01 Nov 2021 | 1,000 | 20,000 (0%) | 0% | 11.1 | 11,140 | Common Stock |
Erin Jones | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2021 | 1,000 | 32,971 | - | - | Stock Option (Right to Buy) | |
Erin Jones | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.34 per share. | 01 Nov 2021 | 1,000 | 21,000 (0%) | 0% | 0.3 | 345 | Common Stock |
Erin Jones | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2021 | 1,000 | 33,971 | - | - | Stock Option (Right to Buy) | |
Erin Jones | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2021 | 1,000 | 34,971 | - | - | Stock Option (Right to Buy) | |
Erin Jones | See Remarks | Sale of securities on an exchange or to another person at price $ 10.71 per share. | 01 Oct 2021 | 1,000 | 20,000 (0%) | 0% | 10.7 | 10,710 | Common Stock |
Erin Jones | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.34 per share. | 01 Oct 2021 | 1,000 | 21,000 (0%) | 0% | 0.3 | 345 | Common Stock |
Erin Jones | See Remarks | Sale of securities on an exchange or to another person at price $ 10.68 per share. | 01 Oct 2021 | 1,000 | 20,000 (0%) | 0% | 10.7 | 10,680 | Common Stock |
Erin Jones | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.34 per share. | 01 Oct 2021 | 1,000 | 21,000 (0%) | 0% | 0.3 | 345 | Common Stock |
Erin Jones | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.34 per share. | 08 Sep 2021 | 2,000 | 47,900 (0%) | 0% | 0.3 | 690 | Common Stock |
Erin Jones | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2021 | 2,000 | 35,971 | - | - | Stock Option (Right to Buy) | |
Erin Jones | See Remarks | Sale of securities on an exchange or to another person at price $ 11.37 per share. | 08 Sep 2021 | 2,000 | 45,900 (0%) | 0% | 11.4 | 22,748 | Common Stock |
Thomas Woiwode | Director | Other type of transaction at price $ 0.00 per share. | 25 Aug 2021 | 6,668 | 0 (0%) | 0% | 0 | Common Stock | |
Thomas Woiwode | Director | Other type of transaction at price $ 0.00 per share. | 25 Aug 2021 | 128 | 128 (0%) | 0% | 0 | Common Stock | |
Thomas Woiwode | Director | Other type of transaction at price $ 0.00 per share. | 25 Aug 2021 | 6,612 | 0 (0%) | 0% | 0 | Common Stock | |
Thomas Woiwode | Director | Other type of transaction at price $ 0.00 per share. | 25 Aug 2021 | 6,612 | 6,612 (0%) | 0% | 0 | Common Stock | |
Thomas Woiwode | Director | Other type of transaction at price $ 0.00 per share. | 25 Aug 2021 | 444,744 | 902,965 (2%) | 1% | 0 | Common Stock | |
Thomas Woiwode | Director | Other type of transaction at price $ 0.00 per share. | 25 Aug 2021 | 6,668 | 6,668 (0%) | 0% | 0 | Common Stock | |
Vassiliki Economides | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 215,000 | 215,000 | - | - | Stock Option (Right to Buy) | |
Richard A. Heyman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
Steve E. Krognes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
Naiyer Rizvi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 937 | 937 | - | - | Stock Option (Right to Buy) | |
Shefali Agarwal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 937 | 937 | - | - | Stock Option (Right to Buy) | |
Judith J. Li | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
Naiyer Rizvi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 38,000 | 38,000 | - | - | Stock Option (Right to Buy) | |
Shefali Agarwal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 38,000 | 38,000 | - | - | Stock Option (Right to Buy) | |
Raphael Rousseau | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.76 per share. | 27 May 2021 | 2,900 | 2,900 (0%) | 0% | 0.8 | 2,201 | Common Stock |
Raphael Rousseau | See Remarks | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 27 May 2021 | 2,900 | 0 (0%) | 0% | 9.0 | 26,112 | Common Stock |
Raphael Rousseau | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2021 | 2,900 | 122,426 | - | - | Stock Option (Right to Buy) | |
Andrew R. Allen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 290,000 | 290,000 | - | - | Stock Option (Right to Buy) | |
Erin Jones | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
Matthew Hawryluk | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
Karin Jooss | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
Raphael Rousseau | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
Roman Yelensky | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.76 per share. | 08 Mar 2021 | 50,724 | 183,948 (0%) | 0% | 0.8 | 38,500 | Common Stock |
Roman Yelensky | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2021 | 50,724 | 0 | - | - | Stock Option (Right to Buy) | |
Roman Yelensky | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
Vijay Yabannavar | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
Rahsaan Thompson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
James Cho | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
Raphael Rousseau | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jan 2021 | 10,000 | 125,326 | - | - | Stock Option (Right to Buy) | |
Raphael Rousseau | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.76 per share. | 19 Jan 2021 | 10,000 | 10,000 (0%) | 0% | 0.8 | 7,600 | Common Stock |
Raphael Rousseau | See Remarks | Sale of securities on an exchange or to another person at price $ 25.07 per share. | 19 Jan 2021 | 10,000 | 0 (0%) | 0% | 25.1 | 250,705 | Common Stock |
Raphael Rousseau | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jan 2021 | 20,000 | 135,326 | - | - | Stock Option (Right to Buy) | |
Raphael Rousseau | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.76 per share. | 19 Jan 2021 | 20,000 | 20,000 (0%) | 0% | 0.8 | 15,200 | Common Stock |
Raphael Rousseau | See Remarks | Sale of securities on an exchange or to another person at price $ 17.53 per share. | 19 Jan 2021 | 20,000 | 0 (0%) | 0% | 17.5 | 350,564 | Common Stock |
Roman Yelensky | See Remarks | Sale of securities on an exchange or to another person at price $ 22.10 per share. | 19 Jan 2021 | 10,000 | 160,624 (0%) | 0% | 22.1 | 221,029 | Common Stock |
Andrew R. Allen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 48,200 | 48,200 (0%) | 0% | 0 | Common Stock | |
Matthew Hawryluk | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 19,600 | 24,198 (0%) | 0% | 0 | Common Stock | |
Karin Jooss | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 27,900 | 349,784 (0%) | 0% | 0 | Common Stock | |
Raphael Rousseau | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 29,700 | 29,700 (0%) | 0% | 0 | Common Stock | |
Roman Yelensky | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 27,400 | 170,624 (0%) | 0% | 0 | Common Stock | |
Vijay Yabannavar | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 28,000 | 31,696 (0%) | 0% | 0 | Common Stock | |
Rahsaan Thompson | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 25,500 | 29,487 (0%) | 0% | 0 | Common Stock | |
Erin Jones | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2020 | 10,000 | 37,971 | - | - | Stock Option (Right to Buy) | |
Erin Jones | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.34 per share. | 17 Aug 2020 | 10,000 | 20,000 (0%) | 0% | 0.3 | 3,450 | Common Stock |
Nicholas J. Simon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
Richard A. Heyman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
Thomas Woiwode | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
Steve E. Krognes | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
Judith Li | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
Rahsaan Thompson | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2020 | 85,000 | 85,000 | - | - | Stock Option (Right to Buy) | |
Andrew R. Allen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2020 | 275,000 | 275,000 | - | - | Stock Option (Right to Buy) | |
Erin Jones | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2020 | 140,000 | 140,000 | - | - | Stock Option (Right to Buy) | |
Jean-Marc Bellemin | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2020 | 110,000 | 110,000 | - | - | Stock Option (Right to Buy) | |
Matthew Hawryluk | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2020 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
Karin Jooss | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2020 | 110,000 | 110,000 | - | - | Stock Option (Right to Buy) | |
Raphael Rousseau | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2020 | 110,000 | 110,000 | - | - | Stock Option (Right to Buy) | |
Roman Yelensky | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2020 | 130,000 | 130,000 | - | - | Stock Option (Right to Buy) | |
Vijay Yabannavar | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2020 | 110,000 | 110,000 | - | - | Stock Option (Right to Buy) | |
Raphael Rousseau | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Aug 2019 | 10,000 | 155,326 | - | - | Stock Option (Right to Buy) | |
Raphael Rousseau | See Remarks | Sale of securities on an exchange or to another person at price $ 10.76 per share. | 21 Aug 2019 | 10,000 | 0 (0%) | 0% | 10.8 | 107,631 | Common Stock |
Raphael Rousseau | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.76 per share. | 21 Aug 2019 | 10,000 | 10,000 (0%) | 0% | 0.8 | 7,600 | Common Stock |
Vijay Yabannavar | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2019 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
Nicholas J. Simon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2019 | 8,570 | 8,570 | - | - | Stock Option (Right to Buy) | |
Peter Svennilson | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2019 | 8,570 | 8,570 | - | - | Stock Option (Right to Buy) | |
Richard A. Heyman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2019 | 8,570 | 8,570 | - | - | Stock Option (Right to Buy) | |
Thomas Woiwode | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2019 | 8,570 | 8,570 | - | - | Stock Option (Right to Buy) | |
Steve E. Krognes | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2019 | 8,570 | 8,570 | - | - | Stock Option (Right to Buy) | |
Judith Li | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2019 | 8,570 | 8,570 | - | - | Stock Option (Right to Buy) | |
Andrew R. Allen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2019 | 180,000 | 180,000 | - | - | Stock Option (Right to Buy) | |
Erin Jones | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2019 | 66,000 | 66,000 | - | - | Stock Option (Right to Buy) | |
Jean-Marc Bellemin | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2019 | 66,000 | 66,000 | - | - | Stock Option (Right to Buy) | |
Matthew Hawryluk | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2019 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
Karin Jooss | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2019 | 66,000 | 66,000 | - | - | Stock Option (Right to Buy) | |
Raphael Rousseau | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2019 | 66,000 | 66,000 | - | - | Stock Option (Right to Buy) | |
Roman Yelensky | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2019 | 66,000 | 66,000 | - | - | Stock Option (Right to Buy) | |
Erin Jones | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2019 | 10,000 | 47,971 | - | - | Stock Option (Right to Buy) | |
Erin Jones | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.34 per share. | 29 Jan 2019 | 10,000 | 10,000 (0%) | 0% | 0.3 | 3,450 | Common Stock |
Peter Svennilson | Director, Ten Percent Owner | 02 Oct 2018 | 3,102,934 | 3,102,934 (124%) | 124% | 0 | Common Stock | ||
Peter Svennilson | Director, Ten Percent Owner | 02 Oct 2018 | 929,022 | 0 | - | - | Series B Convertible Preferred Stock | ||
Peter Svennilson | Director, Ten Percent Owner | 02 Oct 2018 | 2,173,912 | 0 | - | - | Series A Convertible Preferred Stock | ||
Thomas Woiwode | Director, Ten Percent Owner | 02 Oct 2018 | 929,020 | 0 | - | - | Series B Convertible Preferred Stock | ||
Thomas Woiwode | Director, Ten Percent Owner | 02 Oct 2018 | 3,102,929 | 3,102,929 (124%) | 124% | 0 | Common Stock | ||
Thomas Woiwode | Director, Ten Percent Owner | 02 Oct 2018 | 2,173,909 | 0 | - | - | Series A Convertible Preferred Stock | ||
Nicholas J. Simon | Director, Ten Percent Owner | 28 Sep 2018 | 668,896 | 0 | - | - | Series B Convertible Preferred Stock | ||
Nicholas J. Simon | Director, Ten Percent Owner | 28 Sep 2018 | 2,234,112 | 2,567,445 (103%) | 89% | 0 | Common Stock | ||
Nicholas J. Simon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 28 Sep 2018 | 333,333 | 333,333 (1%) | 1% | 15 | 4,999,995 | Common Stock |
Nicholas J. Simon | Director, Ten Percent Owner | 28 Sep 2018 | 1,565,216 | 0 | - | - | Series A Convertible Preferred Stock |